Novel Biologic Promising for Allergic Asthma – MedPage Today


CTV News

Novel Biologic Promising for Allergic Asthma
MedPage Today
SAN DIEGO — A novel first-in-class biologic agent targeting allergic inflammation appeared promising for allergen-induced asthma in a phase IIb trial. AMG 157, an anti-thymic stromal lymphopoietin (TSLP) humanized monoclonal antibody, reduced most …
Researchers discover new potential antibody treatment for asthmaMedical Xpress
Canadian study finds potential antibody treatment for mild asthmaCTV News
Hamilton researchers discover potential asthma treatmentHamilton Spectator

all 11 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.